Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mazza

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|March 24, 1984
Superintensive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's lymphomaP Ricci, G Bandini, G Visani, et al.
Haematologica|October 1, 1989
[New directions in the prognostic evaluation of non-Hodgkin's lymphoma]M Gobbi, S Pileri, N Testoni, et al.
Haematologica|July 1, 1990
[Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)]P Mazza, M Bocchia, P L Zinzani, et al.
Haematologica|October 17, 2001
Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disordersP Mazza, G Palazzo, B Amurri, et al.
Journal of Inorganic Biochemistry|November 1, 1995
Synthesis, structure, and biological activity of organotin compounds with di-2-pyridylketone and phenyl(2-pyridyl) ketone 2-aminobenzoylhydrazonesS Ianelli, P Mazza, M Orcesi, et al.
International Journal of Cardiology|May 1, 2014
Thrombus in transit: a link between pulmonary embolism and neurological embolic eventsJohn Fani Srour, Joseph P Mazza, Afshin Ehasn, et al.
Journal of Inorganic Biochemistry|December 1, 1992
Synthesis, structure, antimicrobial, and genotoxic activities of organotin compounds with 2,6-diacetylpyridine nicotinoyl- and isonicotinoylhydrazonesP Mazza, M Orcesi, C Pelizzi, et al.
Haematologica|March 1, 1984
Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapyP Mazza, F Lauria, F Gherlinzoni, et al.
Seminars in Oncology|December 1, 1990
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histologyF Gherlinzoni, C Guglielmi, P Mazza, et al.
Haematologica|November 7, 2000
Acute leukemia in Jehovah's Witnesses: a challenge for hematologistsP Mazza, G Palazzo, B Amurri, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|March 24, 1984
Superintensive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's lymphomaP Ricci, G Bandini, G Visani, et al.
Haematologica|October 1, 1989
[New directions in the prognostic evaluation of non-Hodgkin's lymphoma]M Gobbi, S Pileri, N Testoni, et al.
Haematologica|July 1, 1990
[Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)]P Mazza, M Bocchia, P L Zinzani, et al.
Haematologica|October 17, 2001
Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disordersP Mazza, G Palazzo, B Amurri, et al.
Journal of Inorganic Biochemistry|November 1, 1995
Synthesis, structure, and biological activity of organotin compounds with di-2-pyridylketone and phenyl(2-pyridyl) ketone 2-aminobenzoylhydrazonesS Ianelli, P Mazza, M Orcesi, et al.
International Journal of Cardiology|May 1, 2014
Thrombus in transit: a link between pulmonary embolism and neurological embolic eventsJohn Fani Srour, Joseph P Mazza, Afshin Ehasn, et al.
Journal of Inorganic Biochemistry|December 1, 1992
Synthesis, structure, antimicrobial, and genotoxic activities of organotin compounds with 2,6-diacetylpyridine nicotinoyl- and isonicotinoylhydrazonesP Mazza, M Orcesi, C Pelizzi, et al.
Haematologica|March 1, 1984
Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapyP Mazza, F Lauria, F Gherlinzoni, et al.
Seminars in Oncology|December 1, 1990
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histologyF Gherlinzoni, C Guglielmi, P Mazza, et al.
Haematologica|November 7, 2000
Acute leukemia in Jehovah's Witnesses: a challenge for hematologistsP Mazza, G Palazzo, B Amurri, et al.
Pageof 18